Sepio Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.08M | Buy |
3,957
+568
| +17% | +$298K | 0.15% | 101 |
|
2025
Q1 | $2.15M | Buy |
3,389
+842
| +33% | +$534K | 0.17% | 99 |
|
2024
Q4 | $1.81M | Sell |
2,547
-4
| -0.2% | -$2.85K | 0.15% | 114 |
|
2024
Q3 | $2.68M | Sell |
2,551
-19
| -0.7% | -$20K | 0.21% | 87 |
|
2024
Q2 | $2.7M | Sell |
2,570
-19
| -0.7% | -$20K | 0.25% | 83 |
|
2024
Q1 | $2.49M | Sell |
2,589
-113
| -4% | -$109K | 0.21% | 99 |
|
2023
Q4 | $2.37M | Sell |
2,702
-563
| -17% | -$495K | 0.2% | 92 |
|
2023
Q3 | $2.69M | Sell |
3,265
-3,718
| -53% | -$3.06M | 0.23% | 95 |
|
2023
Q2 | $5.04M | Buy |
6,983
+68
| +1% | +$49.1K | 0.41% | 64 |
|
2023
Q1 | $5.68M | Sell |
6,915
-411
| -6% | -$338K | 0.52% | 50 |
|
2022
Q4 | $5.29M | Sell |
7,326
-1,295
| -15% | -$934K | 0.46% | 51 |
|
2022
Q3 | $5.94M | Sell |
8,621
-4,800
| -36% | -$3.31M | 0.59% | 37 |
|
2022
Q2 | $7.93M | Buy |
13,421
+5,535
| +70% | +$3.27M | 0.8% | 23 |
|
2022
Q1 | $5.51M | Sell |
7,886
-839
| -10% | -$586K | 0.48% | 56 |
|
2021
Q4 | $5.51M | Sell |
8,725
-42
| -0.5% | -$26.5K | 0.41% | 61 |
|
2021
Q3 | $5.31M | Sell |
8,767
-3,566
| -29% | -$2.16M | 0.44% | 53 |
|
2021
Q2 | $6.89M | Buy |
12,333
+2,933
| +31% | +$1.64M | 0.57% | 36 |
|
2021
Q1 | $4.45M | Sell |
9,400
-55
| -0.6% | -$26K | 0.41% | 65 |
|
2020
Q4 | $4.57M | Sell |
9,455
-1,528
| -14% | -$738K | 0.39% | 61 |
|
2020
Q3 | $6.15M | Sell |
10,983
-427
| -4% | -$239K | 0.67% | 42 |
|
2020
Q2 | $7.12M | Sell |
11,410
-348
| -3% | -$217K | 0.84% | 27 |
|
2020
Q1 | $5.75M | Buy |
11,758
+309
| +3% | +$151K | 0.76% | 35 |
|
2019
Q4 | $4.3M | Sell |
11,449
-1,116
| -9% | -$419K | 0.41% | 80 |
|
2019
Q3 | $3.49M | Buy |
12,565
+1,880
| +18% | +$522K | 0.36% | 89 |
|
2019
Q2 | $3.34M | Buy |
10,685
+107
| +1% | +$33.5K | 0.45% | 69 |
|
2019
Q1 | $4.34M | Sell |
10,578
-1,629
| -13% | -$669K | 0.59% | 45 |
|
2018
Q4 | $4.56M | Buy |
+12,207
| New | +$4.56M | 0.33% | 49 |
|